The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of trabectedin when administered in the inpatient vs. outpatient setting in a subset analysis of a phase III randomized clinical trial.
 
Robin Lewis Jones
Consulting or Advisory Role - Adaptimmune; Daiichi Sankyo; Eisai; Immodulon Therapeutics; Immune Design; Lilly; Merck Serono; Morphotek; TRACON Pharma
Research Funding - GlaxoSmithKline (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Robert G Maki
Honoraria - Novartis
Consulting or Advisory Role - Arcus Ventures; Bayer; Eisai; Gem Pharmaceuticals; KARNO Pharm; Lilly; TRACON Pharma
Research Funding - Eisai (Inst); SARC: Sarcoma Alliance for Research though Collaboration (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate
Travel, Accommodations, Expenses - Bayer; GlaxoSmithKline; TRACON Pharma
 
Shreyaskumar Patel
Consulting or Advisory Role - Bayer; CytRx Corporation; Eisai; EMD Serono; Janssen Research & Development; Lilly; Novartis
Research Funding - Eisai; Janssen Research & Development; Morphotek
 
George C. Wang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Chu Ri Shin
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Johnson & Johnson
 
Roland Elmar Knoblauch
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Trilok V. Parekh
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Margaret von Mehren
Consulting or Advisory Role - Blueprint Medicines; CytRx Corporation; Eisai; Janssen Oncology
Research Funding - ArQule
Travel, Accommodations, Expenses - ARIAD; Blueprint Medicines; Eisai; Janssen Oncology; Novartis
 
George D. Demetri
Leadership - Blueprint Medicines
Stock and Other Ownership Interests - Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics
Consulting or Advisory Role - Adaptimmune; Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; Daiichi Sankyo; Eisai; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen Oncology; Kolltan Pharmaceuticals; Kyocera; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group; ZIOPHARM Oncology
Research Funding - Bayer (Inst); Janssen Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - Novartis (Inst)